Literature DB >> 8757799

Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain.

N M Low1, P H Holliger, G Winter.   

Abstract

Human antibodies can now be isolated from antibody repertoires displayed on the surface of filamentous bacteriophage in a process that mimics the primary immune response. Here we have attempted to mimic the secondary response, the natural process of affinity maturation of antibodies occurring in germinal centres, by multiple cycles of random mutation and selection. Phage displaying a human antibody fragment recognising the hapten 2-phenyl-5-oxazolone were grown in a mutator strain of bacteria (Escherichia coli: mutD5) to generate a large repertoire of antibodies that should include the majority of possible single nucleotide point mutations. The repertoire of phage antibody mutants was then selected by binding to hapten. By multiple rounds of growth in the mutator strain, and increasingly stringent selection, we succeeded in isolating mutants with improved binding affinities; furthermore, the distribution of mutations and nucleotide substitution preferences strongly resembled those of somatic hypermutation. We then constructed a genealogical tree from the sequences of mutants taken at different rounds, and identified four sequentially acquired mutations that together improve the binding affinity of the antibody by a factor of 100-fold (from Kd 320 nM to 3.2 nM).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757799     DOI: 10.1006/jmbi.1996.0406

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  29 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies.

Authors:  P S Daugherty; G Chen; B L Iverson; G Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  Isolation of receptor-ligand pairs by capture of long-lived multivalent interaction complexes.

Authors:  Ruud M T de Wildt; Ian M Tomlinson; Jennifer L Ong; Philipp Holliger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 4.  Molecular targeting of angiogenesis for imaging and therapy.

Authors:  Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-05       Impact factor: 9.236

5.  Development of a novel mammalian cell surface antibody display platform.

Authors:  Chen Zhou; Frederick W Jacobsen; Ling Cai; Qing Chen; Weyen David Shen
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

Review 6.  Mining human antibody repertoires.

Authors:  Roger R Beerli; Christoph Rader
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

7.  A general method for greatly improving the affinity of antibodies by using combinatorial libraries.

Authors:  Arvind Rajpal; Nurten Beyaz; Lauric Haber; Guido Cappuccilli; Helena Yee; Ramesh R Bhatt; Toshihiko Takeuchi; Richard A Lerner; Roberto Crea
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

8.  Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries.

Authors:  J Hanes; L Jermutus; S Weber-Bornhauser; H R Bosshard; A Plückthun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Large scale production of phage antibody libraries using a bioreactor.

Authors:  Fortunato Ferrara; Chang-Yub Kim; Leslie A Naranjo; Andrew R M Bradbury
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 10.  Novel antibodies targeting immune regulatory checkpoints for cancer therapy.

Authors:  Chern Siang Lee; Mark Cragg; Martin Glennie; Peter Johnson
Journal:  Br J Clin Pharmacol       Date:  2013-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.